TIM3-targeted delivery of venetoclax overcomes drug resistance and reinvigorates NK cell activity in acute myeloid leukemia. (nature.com)

Authors: Wang Q … Qian P Journal: Nature Cancer Published: 2026-08-12 DOI: https://doi.org/10.1038/s43018-026-01217-z